World model AI firms stay tight-lipped on product plans
Original: World model companies are keeping a lot of secrets
Why This Matters
World models may underpin the next wave of robotics and spatial AI, but zero product clarity makes it hard to assess real progress.
At the All In conference in September 2026, a panel on world models revealed that leading players AMI Labs and World Labs are deliberately keeping product roadmaps secret. Both companies have raised significant funding but remain firmly in research mode, with no disclosed commercialization timelines.
World models — AI systems built around spatial intelligence — are attracting serious money and attention, but almost no transparency. The two biggest names in the space, Yann LeCun's AMI Labs and Fei-Fei Li's World Labs, have accumulated substantial buzz and funding while revealing little about what they actually plan to sell or when.
At a TechCrunch-moderated panel at the All In conference, AMI Labs co-founder and VP of World Models Michael Rabbat declined to detail the company's work: 'We'll talk about it when we're ready to talk about it.' In a follow-up email, he said, 'We're still in a research and building phase, so we're not talking publicly about any product plans or timeline.' AMI is under a year old, which makes some secrecy reasonable — but the pattern holds across the entire space.
World Labs' Marble is arguably the most developed product yet, with demos covering media creation, explorable video game environments, and CGI effects, though it reads more like a capability showcase than a commercial launch.
The opacity even blindsides suppliers. Alex de Vigan, CEO of Physicl — a data provider for world model companies — says he knows his data is being used but has no idea for what. 'I wish they would tell us more. We could build more useful data if we knew what they were working on,' he said.
The ambiguity is partly structural: world model tech could apply to robotics, self-driving, interactive video, biomedicine, or manufacturing. AMI has already touched all of those through various projects including its Nabia medical AI partnership. With fundraising still easy, there's little pressure to narrow focus — and possibly strategic risk in doing so.